Search
for
Sort by
Research 271–300 of 1000+
- Selective Pituitary Resistance to Thyroid Hormone: Clinical Hyperthyroidism with High TSH on Levothyroxine Administration in I-131 Ablated “Graves Disease”
- Impact of Cyproterone Acetate and Ethinylestradiol on Clomiphene Resistant PCOS Patient with High Serum AMH level
- Prevalence and Levels of Thyroid Autoantibodies in Polycystic Ovary Syndrome—Impact of TSH- and BMI-Matched Comparisons: A Systematic Review and Meta-Analysis
- De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia
- Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance
- VIRILISING OVARIAN TUMOUR
- Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis
- Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
- Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides
- The Association of Cutaneous Lichen Planus and Metabolic Syndrome: A Case-Control Study
- Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa
- The impact of polycystic ovary syndrome on women’s quality of life: Nursing guidelines for its
- REPRODUCTIVE HORMONE LEVELS AND METABOLIC SYNDROME IN WOMEN WITH POLYCYSTIC OVARY SYNDROME IN SANA'A, YEMEN
- Lean Women with Polycystic Ovary Syndrome
- Feeding the skin: The emerging role of nutritional intervention in dermatological disorders
- Lipid profile in androgenetic alopecia
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Is There Any Association Between Clinical and Biochemical Hyperandrogenism in Women With Female Pattern Hair Loss?
- Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks
- Phenotypic Characterization of Patients with Polycystic Ovary Syndrome in a Population from the Ecuadorian Andes: A Cross-Sectional Study
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Is early onset androgenic alopecia a marker of metabolic syndrome and carotid artery atherosclerosis in young Indian male patients?
- A Comprehensive Review of Acne Vulgaris
- COVID-19 and hypopituitarism
- Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
- Association of single nucleotide polymorphisms in the <i>RAB5B</i> gene 3′UTR region with polycystic ovary syndrome in Chinese Han women
- Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome
- A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study